Literature DB >> 26453544

Association of apical rocking with long-term major adverse cardiac events in patients undergoing cardiac resynchronization therapy.

Abdul Ghani1, Peter Paul H M Delnoy1, Jan Paul Ottervanger1, Anand R Ramdat Misier1, Jaap Jan J Smit1, Ahmet Adiyaman1, Arif Elvan2.   

Abstract

AIMS: Correctly identifying patients who will benefit from cardiac resynchronization therapy (CRT) is still challenging. 'Apical rocking' is observed in asynchronously contracting ventricles and is associated with echocardiographic response to CRT. The association of apical rocking and long-term clinical outcome is however unknown at present. We assessed the predictive value of left ventricular (LV) apical rocking on a long-term clinical outcome in patients treated with CRT. METHODS AND
RESULTS: Consecutive heart failure patients treated with primary indication for CRT-D between 2005 and 2009 were included in a prospective registry. Echocardiography was performed prior to CRT to assess apical rocking, defined as motion of the LV apical myocardium perpendicular to the LV long axis. Major adverse cardiac event (MACE) was defined as combined end point of cardiac death and/or heart failure hospitalization and/or appropriate therapy (ATP and/or ICD shocks). All echocardiograms were assessed by independent cardiologists, blinded for clinical data. Multivariable analyses were performed to adjust for potential confounders. Two hundred and ninety-five patients with echocardiography prior to implantation were included in the final analyses. Apical rocking was present in 45% of the study patients. Apical rocking was significantly more common in younger patients, females, patients with sinus rhythm, non-ischaemic cardiomyopathy, and in patients with LBBB and wider QRS duration. During a mean clinical follow-up of 5.2 ± 1.6 years, 92 (31%) patients reached the end point of the study (MACE). Patients with MACE had shorter QRS duration, had more ischaemic cardiomyopathy, and were more often on Amiodarone. In univariate analyses, MACE was associated with shorter QRS duration, ischaemic aetiology, and the absence of apical rocking. After multivariable analyses, apical rocking was associated with less MACE (hazards ratio, HR 0.44, 95% confidence interval, CI 0.25-0.77).
CONCLUSION: Apical rocking is an independent predictor of a favourable long-term outcome in CRT-D patients. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  ICD therapy; apical rocking; cardiac resynchronization therapy; long-term outcome

Mesh:

Year:  2015        PMID: 26453544      PMCID: PMC4882884          DOI: 10.1093/ehjci/jev236

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  26 in total

Review 1.  Echocardiography, dyssynchrony, and the response to cardiac resynchronization therapy.

Authors:  Cheuk-Man Yu; John E Sanderson; John Gorcsan
Journal:  Eur Heart J       Date:  2010-08-13       Impact factor: 29.983

2.  Predictors of response to cardiac resynchronization therapy (PROSPECT)--study design.

Authors:  Cheuk-Man Yu; William T Abraham; Jeroen Bax; Eugene Chung; Michelle Fedewa; Stefano Ghio; Christophe Leclercq; Angel R León; John Merlino; Petros Nihoyannopoulos; Dean Notabartolo; Jing Ping Sun; Luigi Tavazzi
Journal:  Am Heart J       Date:  2005-04       Impact factor: 4.749

Review 3.  Echocardiography and noninvasive imaging in cardiac resynchronization therapy: results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) study in perspective.

Authors:  Jeroen J Bax; John Gorcsan
Journal:  J Am Coll Cardiol       Date:  2009-05-26       Impact factor: 24.094

4.  Longitudinal strain delay index by speckle tracking imaging: a new marker of response to cardiac resynchronization therapy.

Authors:  Pascal Lim; Adisai Buakhamsri; Zoran B Popovic; Neil L Greenberg; Dimpi Patel; James D Thomas; Richard A Grimm
Journal:  Circulation       Date:  2008-08-25       Impact factor: 29.690

5.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher
Journal:  Eur Heart J       Date:  2012-05-19       Impact factor: 29.983

6.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

7.  Apical transverse motion as surrogate parameter to determine regional left ventricular function inhomogeneities: a new, integrative approach to left ventricular asynchrony assessment.

Authors:  Jens-Uwe Voigt; Thomas-Michael Schneider; Stephan Korder; Mariola Szulik; Emre Gürel; Werner G Daniel; Frank Rademakers; Frank A Flachskampf
Journal:  Eur Heart J       Date:  2009-03-18       Impact factor: 29.983

8.  Qualitative observation of left ventricular multiphasic septal motion and septal-to-lateral apical shuffle predicts left ventricular reverse remodeling after cardiac resynchronization therapy.

Authors:  Annemieke H M Jansen; Jan melle van Dantzig; Franck Bracke; Albert Meijer; Kathinka H Peels; Renee B A van den Brink; Emile C Cheriex; Ben J M Delemarre; Pol A van der Wouw; Hendrikus H M Korsten; Norbert M van Hemel
Journal:  Am J Cardiol       Date:  2007-02-15       Impact factor: 2.778

9.  Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy.

Authors:  Matthew S Suffoletto; Kaoru Dohi; Maxime Cannesson; Samir Saba; John Gorcsan
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

10.  Toward understanding response to cardiac resynchronization therapy: left ventricular dyssynchrony is only one of multiple mechanisms.

Authors:  Chirine Parsai; Bart Bijnens; George Ross Sutherland; Aigul Baltabaeva; Piet Claus; Maciej Marciniak; Vince Paul; Mike Scheffer; Erwan Donal; Geneviève Derumeaux; Lisa Anderson
Journal:  Eur Heart J       Date:  2008-11-11       Impact factor: 29.983

View more
  3 in total

1.  Cardiac resynchronization therapy responders can be better identified by specific signatures in myocardial function.

Authors:  Jens-Uwe Voigt
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-11-20       Impact factor: 6.875

2.  Rational and design of EuroCRT: an international observational study on multi-modality imaging and cardiac resynchronization therapy.

Authors:  Erwan Donal; Victoria Delgado; Julien Magne; Chiara Bucciarelli-Ducci; Christophe Leclercq; Bernard Cosyns; Marta Sitges; Thor Edvardsen; Elif Sade; Ivan Stankovic; Eustachio Agricola; Maurizio Galderisi; Patrizio Lancellotti; Alfredo Hernandez; Sven Plein; Denisa Muraru; Ehud Schwammenthal; Gerhard Hindricks; Bogdan A Popescu; Gilbert Habib
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2017-10-01       Impact factor: 6.875

3.  Regional contributions to left ventricular stroke volume determined by cardiac magnetic resonance imaging in cardiac resynchronization therapy.

Authors:  Björn Östenson; Ellen Ostenfeld; Anna Werther-Evaldsson; Anders Roijer; Zoltan Bakos; Mikael Kanski; Einar Heiberg; Håkan Arheden; Rasmus Borgquist; Marcus Carlsson
Journal:  BMC Cardiovasc Disord       Date:  2021-10-26       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.